NEUROENDOCRINE CARCINOMA OF PROSTATE

Clinical trials for NEUROENDOCRINE CARCINOMA OF PROSTATE explained in plain language.

Never miss a new study

Get alerted when new NEUROENDOCRINE CARCINOMA OF PROSTATE trials appear

Sign up with your email to follow new studies for NEUROENDOCRINE CARCINOMA OF PROSTATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for rare, aggressive cancers: trial tests Immune-Boosting drug

Disease control Recruiting now

This study is testing a new drug called tarlatamab for people with a rare and aggressive type of cancer called extrapulmonary neuroendocrine carcinoma (EPNEC). The cancer has returned or worsened after standard chemotherapy. The trial will see if tarlatamab, which works by direct…

Matched conditions: NEUROENDOCRINE CARCINOMA OF PROSTATE

Phase: PHASE2 • Sponsor: Inkeun Park • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

NEUROENDOCRINE CARCINOMA OF PROSTATE

Get alerted when new NEUROENDOCRINE CARCINOMA OF PROSTATE trials appear

New hope for rare, aggressive cancers: trial tests Immune-Boosting drug